Global Prenatal Cell-Free DNA Screening Market Growth (Status and Outlook) 2026-2032
The global Prenatal Cell-Free DNA Screening market size is predicted to grow from US$ 755 million in 2025 to US$ 1415 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual?s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider?s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
LPI (LP Information)' newest research report, the ?Prenatal Cell-Free DNA Screening Industry Forecast? looks at past sales and reviews total world Prenatal Cell-Free DNA Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Prenatal Cell-Free DNA Screening sales for 2026 through 2032. With Prenatal Cell-Free DNA Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Cell-Free DNA Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Cell-Free DNA Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Cell-Free DNA Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prenatal Cell-Free DNA Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Cell-Free DNA Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Cell-Free DNA Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Cell-Free DNA Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Prenatal Cell-Free DNA Screening refers to a prenatal screening approach that analyzes fetal genetic signals present as cell-free DNA fragments in a pregnant individual?s blood sample to estimate the risk of specific fetal genetic abnormalities without invasive procedures. The process involves standardized sample collection, laboratory analysis, computational interpretation, and structured clinical reporting, with results used to guide decisions about confirmatory diagnostic testing and ongoing prenatal care management. It is designed as a screening tool rather than a definitive diagnosis, and its clinical value depends on analytical accuracy, quality assurance, and responsible interpretation within established prenatal counseling and follow-up workflows.
Prenatal Cell-Free DNA Screening is now widely viewed as the most scalable pathway to bring DNA-based risk assessment into routine prenatal care, because it combines a noninvasive workflow with high-throughput laboratory operations and standardized reporting. From a research report perspective, the market is driven by continued substitution away from traditional serum-based screening, broader clinical acceptance of clear follow-up pathways, and ongoing improvements in bioinformatics and quality control that reduce test failures and strengthen performance in challenging samples. Competitive differentiation is increasingly defined by reliability at scale, analytical robustness under low fetal signal conditions, transparent clinical limitations, and the provider?s ability to integrate ordering, consent, reporting, and genetic counseling into a cohesive service model. At the same time, payer policy and regulatory scrutiny are shaping market structure, favoring providers that can demonstrate strong clinical validation, consistent end-to-end execution, and disciplined expansion of test scope without compromising interpretability or clinical governance.
LPI (LP Information)' newest research report, the ?Prenatal Cell-Free DNA Screening Industry Forecast? looks at past sales and reviews total world Prenatal Cell-Free DNA Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Prenatal Cell-Free DNA Screening sales for 2026 through 2032. With Prenatal Cell-Free DNA Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Cell-Free DNA Screening industry.
This Insight Report provides a comprehensive analysis of the global Prenatal Cell-Free DNA Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prenatal Cell-Free DNA Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Prenatal Cell-Free DNA Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Cell-Free DNA Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Cell-Free DNA Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Cell-Free DNA Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prenatal Cell-Free DNA Screening Market Size (2021-2032)
2.1.2 Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Prenatal Cell-Free DNA Screening by Country/Region (2021, 2025 & 2032)
2.2 Prenatal Cell-Free DNA Screening Segment by Type
2.2.1 Core Condition Screening
2.2.2 Expanded Condition Screening
2.2.3 Prenatal Cell-Free DNA Screening Market Size by Type
2.2.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
2.3 Prenatal Cell-Free DNA Screening Segment by Sequencing Method
2.3.1 Whole Genome Sequencing
2.3.2 Targeted Sequencing
2.3.3 Others
2.3.4 Prenatal Cell-Free DNA Screening Market Size by Sequencing Method
2.3.4.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2026)
2.4 Prenatal Cell-Free DNA Screening Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Prenatal Cell-Free DNA Screening Market Size by Service Model
2.4.4.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2026)
2.5 Prenatal Cell-Free DNA Screening Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Prenatal Cell-Free DNA Screening Market Size by Application
2.5.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
3 PRENATAL CELL-FREE DNA SCREENING MARKET SIZE BY PLAYER
3.1 Prenatal Cell-Free DNA Screening Market Size Market Share by Player
3.1.1 Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
3.2 Global Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRENATAL CELL-FREE DNA SCREENING BY REGION
4.1 Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
4.2 Global Prenatal Cell-Free DNA Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.4 APAC Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.5 Europe Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
5.2 Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3 Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
6.2 APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
6.3 APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
7.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prenatal Cell-Free DNA Screening by Region (2021-2026)
8.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRENATAL CELL-FREE DNA SCREENING MARKET FORECAST
10.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.2 Americas Prenatal Cell-Free DNA Screening Forecast
10.1.3 APAC Prenatal Cell-Free DNA Screening Forecast
10.1.4 Europe Prenatal Cell-Free DNA Screening Forecast
10.1.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast
10.2 Americas Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.2.1 United States Market Prenatal Cell-Free DNA Screening Forecast
10.2.2 Canada Market Prenatal Cell-Free DNA Screening Forecast
10.2.3 Mexico Market Prenatal Cell-Free DNA Screening Forecast
10.2.4 Brazil Market Prenatal Cell-Free DNA Screening Forecast
10.3 APAC Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.3.1 China Prenatal Cell-Free DNA Screening Market Forecast
10.3.2 Japan Market Prenatal Cell-Free DNA Screening Forecast
10.3.3 Korea Market Prenatal Cell-Free DNA Screening Forecast
10.3.4 Southeast Asia Market Prenatal Cell-Free DNA Screening Forecast
10.3.5 India Market Prenatal Cell-Free DNA Screening Forecast
10.3.6 Australia Market Prenatal Cell-Free DNA Screening Forecast
10.4 Europe Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Prenatal Cell-Free DNA Screening Forecast
10.4.2 France Market Prenatal Cell-Free DNA Screening Forecast
10.4.3 UK Market Prenatal Cell-Free DNA Screening Forecast
10.4.4 Italy Market Prenatal Cell-Free DNA Screening Forecast
10.4.5 Russia Market Prenatal Cell-Free DNA Screening Forecast
10.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Prenatal Cell-Free DNA Screening Forecast
10.5.2 South Africa Market Prenatal Cell-Free DNA Screening Forecast
10.5.3 Israel Market Prenatal Cell-Free DNA Screening Forecast
10.5.4 Turkey Market Prenatal Cell-Free DNA Screening Forecast
10.6 Global Prenatal Cell-Free DNA Screening Forecast by Type (2027-2032)
10.7 Global Prenatal Cell-Free DNA Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Prenatal Cell-Free DNA Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Natera
11.1.1 Natera Company Information
11.1.2 Natera Prenatal Cell-Free DNA Screening Product Offered
11.1.3 Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Natera Main Business Overview
11.1.5 Natera Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Prenatal Cell-Free DNA Screening Product Offered
11.2.3 Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Prenatal Cell-Free DNA Screening Product Offered
11.3.3 Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Prenatal Cell-Free DNA Screening Product Offered
11.4.3 MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product Offered
11.5.3 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 SYNLAB
11.6.1 SYNLAB Company Information
11.6.2 SYNLAB Prenatal Cell-Free DNA Screening Product Offered
11.6.3 SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SYNLAB Main Business Overview
11.6.5 SYNLAB Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Prenatal Cell-Free DNA Screening Product Offered
11.7.3 Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 GGA
11.8.1 GGA Company Information
11.8.2 GGA Prenatal Cell-Free DNA Screening Product Offered
11.8.3 GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GGA Main Business Overview
11.8.5 GGA Latest Developments
11.9 Fulgent Genetics
11.9.1 Fulgent Genetics Company Information
11.9.2 Fulgent Genetics Prenatal Cell-Free DNA Screening Product Offered
11.9.3 Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fulgent Genetics Main Business Overview
11.9.5 Fulgent Genetics Latest Developments
11.10 BillionToOne
11.10.1 BillionToOne Company Information
11.10.2 BillionToOne Prenatal Cell-Free DNA Screening Product Offered
11.10.3 BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BillionToOne Main Business Overview
11.10.5 BillionToOne Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
11.11.3 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Berry Genomics
11.12.1 Berry Genomics Company Information
11.12.2 Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
11.12.3 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Genomics Main Business Overview
11.12.5 Berry Genomics Latest Developments
11.13 Annaroad
11.13.1 Annaroad Company Information
11.13.2 Annaroad Prenatal Cell-Free DNA Screening Product Offered
11.13.3 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Annaroad Main Business Overview
11.13.5 Annaroad Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Prenatal Cell-Free DNA Screening Product Offered
11.14.3 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product Offered
11.15.3 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
11.16 BGI Genomics
11.16.1 BGI Genomics Company Information
11.16.2 BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
11.16.3 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BGI Genomics Main Business Overview
11.16.5 BGI Genomics Latest Developments
11.17 Berry Genomics
11.17.1 Berry Genomics Company Information
11.17.2 Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
11.17.3 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Berry Genomics Main Business Overview
11.17.5 Berry Genomics Latest Developments
11.18 Annaroad
11.18.1 Annaroad Company Information
11.18.2 Annaroad Prenatal Cell-Free DNA Screening Product Offered
11.18.3 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Annaroad Main Business Overview
11.18.5 Annaroad Latest Developments
11.19 Genesky
11.19.1 Genesky Company Information
11.19.2 Genesky Prenatal Cell-Free DNA Screening Product Offered
11.19.3 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Genesky Main Business Overview
11.19.5 Genesky Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Prenatal Cell-Free DNA Screening Market Size (2021-2032)
2.1.2 Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Prenatal Cell-Free DNA Screening by Country/Region (2021, 2025 & 2032)
2.2 Prenatal Cell-Free DNA Screening Segment by Type
2.2.1 Core Condition Screening
2.2.2 Expanded Condition Screening
2.2.3 Prenatal Cell-Free DNA Screening Market Size by Type
2.2.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
2.3 Prenatal Cell-Free DNA Screening Segment by Sequencing Method
2.3.1 Whole Genome Sequencing
2.3.2 Targeted Sequencing
2.3.3 Others
2.3.4 Prenatal Cell-Free DNA Screening Market Size by Sequencing Method
2.3.4.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2026)
2.4 Prenatal Cell-Free DNA Screening Segment by Service Model
2.4.1 Public Health Program
2.4.2 Consumer
2.4.3 Others
2.4.4 Prenatal Cell-Free DNA Screening Market Size by Service Model
2.4.4.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032)
2.4.4.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2026)
2.5 Prenatal Cell-Free DNA Screening Segment by Application
2.5.1 Public Hospitals
2.5.2 Private Hospitals
2.5.3 Prenatal Cell-Free DNA Screening Market Size by Application
2.5.3.1 Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.3.2 Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
3 PRENATAL CELL-FREE DNA SCREENING MARKET SIZE BY PLAYER
3.1 Prenatal Cell-Free DNA Screening Market Size Market Share by Player
3.1.1 Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026)
3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
3.2 Global Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRENATAL CELL-FREE DNA SCREENING BY REGION
4.1 Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
4.2 Global Prenatal Cell-Free DNA Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.4 APAC Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.5 Europe Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
5.2 Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
5.3 Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026)
6.2 APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
6.3 APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026)
7.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Prenatal Cell-Free DNA Screening by Region (2021-2026)
8.2 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRENATAL CELL-FREE DNA SCREENING MARKET FORECAST
10.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.1 Global Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.1.2 Americas Prenatal Cell-Free DNA Screening Forecast
10.1.3 APAC Prenatal Cell-Free DNA Screening Forecast
10.1.4 Europe Prenatal Cell-Free DNA Screening Forecast
10.1.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast
10.2 Americas Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.2.1 United States Market Prenatal Cell-Free DNA Screening Forecast
10.2.2 Canada Market Prenatal Cell-Free DNA Screening Forecast
10.2.3 Mexico Market Prenatal Cell-Free DNA Screening Forecast
10.2.4 Brazil Market Prenatal Cell-Free DNA Screening Forecast
10.3 APAC Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.3.1 China Prenatal Cell-Free DNA Screening Market Forecast
10.3.2 Japan Market Prenatal Cell-Free DNA Screening Forecast
10.3.3 Korea Market Prenatal Cell-Free DNA Screening Forecast
10.3.4 Southeast Asia Market Prenatal Cell-Free DNA Screening Forecast
10.3.5 India Market Prenatal Cell-Free DNA Screening Forecast
10.3.6 Australia Market Prenatal Cell-Free DNA Screening Forecast
10.4 Europe Prenatal Cell-Free DNA Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Prenatal Cell-Free DNA Screening Forecast
10.4.2 France Market Prenatal Cell-Free DNA Screening Forecast
10.4.3 UK Market Prenatal Cell-Free DNA Screening Forecast
10.4.4 Italy Market Prenatal Cell-Free DNA Screening Forecast
10.4.5 Russia Market Prenatal Cell-Free DNA Screening Forecast
10.5 Middle East & Africa Prenatal Cell-Free DNA Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Prenatal Cell-Free DNA Screening Forecast
10.5.2 South Africa Market Prenatal Cell-Free DNA Screening Forecast
10.5.3 Israel Market Prenatal Cell-Free DNA Screening Forecast
10.5.4 Turkey Market Prenatal Cell-Free DNA Screening Forecast
10.6 Global Prenatal Cell-Free DNA Screening Forecast by Type (2027-2032)
10.7 Global Prenatal Cell-Free DNA Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Prenatal Cell-Free DNA Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 Natera
11.1.1 Natera Company Information
11.1.2 Natera Prenatal Cell-Free DNA Screening Product Offered
11.1.3 Natera Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Natera Main Business Overview
11.1.5 Natera Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Prenatal Cell-Free DNA Screening Product Offered
11.2.3 Labcorp Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Information
11.3.2 Quest Diagnostics Prenatal Cell-Free DNA Screening Product Offered
11.3.3 Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Quest Diagnostics Main Business Overview
11.3.5 Quest Diagnostics Latest Developments
11.4 MedGenome
11.4.1 MedGenome Company Information
11.4.2 MedGenome Prenatal Cell-Free DNA Screening Product Offered
11.4.3 MedGenome Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 MedGenome Main Business Overview
11.4.5 MedGenome Latest Developments
11.5 Mayo Clinic Laboratories
11.5.1 Mayo Clinic Laboratories Company Information
11.5.2 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product Offered
11.5.3 Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Mayo Clinic Laboratories Main Business Overview
11.5.5 Mayo Clinic Laboratories Latest Developments
11.6 SYNLAB
11.6.1 SYNLAB Company Information
11.6.2 SYNLAB Prenatal Cell-Free DNA Screening Product Offered
11.6.3 SYNLAB Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SYNLAB Main Business Overview
11.6.5 SYNLAB Latest Developments
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Information
11.7.2 Myriad Genetics Prenatal Cell-Free DNA Screening Product Offered
11.7.3 Myriad Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Myriad Genetics Main Business Overview
11.7.5 Myriad Genetics Latest Developments
11.8 GGA
11.8.1 GGA Company Information
11.8.2 GGA Prenatal Cell-Free DNA Screening Product Offered
11.8.3 GGA Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 GGA Main Business Overview
11.8.5 GGA Latest Developments
11.9 Fulgent Genetics
11.9.1 Fulgent Genetics Company Information
11.9.2 Fulgent Genetics Prenatal Cell-Free DNA Screening Product Offered
11.9.3 Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Fulgent Genetics Main Business Overview
11.9.5 Fulgent Genetics Latest Developments
11.10 BillionToOne
11.10.1 BillionToOne Company Information
11.10.2 BillionToOne Prenatal Cell-Free DNA Screening Product Offered
11.10.3 BillionToOne Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 BillionToOne Main Business Overview
11.10.5 BillionToOne Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
11.11.3 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Berry Genomics
11.12.1 Berry Genomics Company Information
11.12.2 Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
11.12.3 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Genomics Main Business Overview
11.12.5 Berry Genomics Latest Developments
11.13 Annaroad
11.13.1 Annaroad Company Information
11.13.2 Annaroad Prenatal Cell-Free DNA Screening Product Offered
11.13.3 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Annaroad Main Business Overview
11.13.5 Annaroad Latest Developments
11.14 Genesky
11.14.1 Genesky Company Information
11.14.2 Genesky Prenatal Cell-Free DNA Screening Product Offered
11.14.3 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Genesky Main Business Overview
11.14.5 Genesky Latest Developments
11.15 Weihansi Biomedical Technology
11.15.1 Weihansi Biomedical Technology Company Information
11.15.2 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product Offered
11.15.3 Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Weihansi Biomedical Technology Main Business Overview
11.15.5 Weihansi Biomedical Technology Latest Developments
11.16 BGI Genomics
11.16.1 BGI Genomics Company Information
11.16.2 BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
11.16.3 BGI Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 BGI Genomics Main Business Overview
11.16.5 BGI Genomics Latest Developments
11.17 Berry Genomics
11.17.1 Berry Genomics Company Information
11.17.2 Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
11.17.3 Berry Genomics Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Berry Genomics Main Business Overview
11.17.5 Berry Genomics Latest Developments
11.18 Annaroad
11.18.1 Annaroad Company Information
11.18.2 Annaroad Prenatal Cell-Free DNA Screening Product Offered
11.18.3 Annaroad Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Annaroad Main Business Overview
11.18.5 Annaroad Latest Developments
11.19 Genesky
11.19.1 Genesky Company Information
11.19.2 Genesky Prenatal Cell-Free DNA Screening Product Offered
11.19.3 Genesky Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Genesky Main Business Overview
11.19.5 Genesky Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Prenatal Cell-Free DNA Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Condition Screening
Table 4. Major Players of Expanded Condition Screening
Table 5. Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Whole Genome Sequencing
Table 9. Major Players of Targeted Sequencing
Table 10. Major Players of Others
Table 11. Prenatal Cell-Free DNA Screening Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2021-2026) & ($ millions)
Table 13. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2026)
Table 14. Major Players of Public Health Program
Table 15. Major Players of Consumer
Table 16. Major Players of Others
Table 17. Prenatal Cell-Free DNA Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Prenatal Cell-Free DNA Screening Market Size by Service Model (2021-2026) & ($ millions)
Table 19. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2026)
Table 20. Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 23. Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
Table 25. Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
Table 26. Prenatal Cell-Free DNA Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 31. Global Prenatal Cell-Free DNA Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 35. Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 37. Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 39. APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 41. APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 45. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Prenatal Cell-Free DNA Screening
Table 51. Key Market Challenges & Risks of Prenatal Cell-Free DNA Screening
Table 52. Key Industry Trends of Prenatal Cell-Free DNA Screening
Table 53. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Natera Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 58. Natera Prenatal Cell-Free DNA Screening Product Offered
Table 59. Natera Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Natera Main Business
Table 61. Natera Latest Developments
Table 62. Labcorp Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 63. Labcorp Prenatal Cell-Free DNA Screening Product Offered
Table 64. Labcorp Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Labcorp Main Business
Table 66. Labcorp Latest Developments
Table 67. Quest Diagnostics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 68. Quest Diagnostics Prenatal Cell-Free DNA Screening Product Offered
Table 69. Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Quest Diagnostics Main Business
Table 71. Quest Diagnostics Latest Developments
Table 72. MedGenome Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 73. MedGenome Prenatal Cell-Free DNA Screening Product Offered
Table 74. MedGenome Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedGenome Main Business
Table 76. MedGenome Latest Developments
Table 77. Mayo Clinic Laboratories Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 78. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product Offered
Table 79. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mayo Clinic Laboratories Main Business
Table 81. Mayo Clinic Laboratories Latest Developments
Table 82. SYNLAB Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 83. SYNLAB Prenatal Cell-Free DNA Screening Product Offered
Table 84. SYNLAB Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. SYNLAB Main Business
Table 86. SYNLAB Latest Developments
Table 87. Myriad Genetics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 88. Myriad Genetics Prenatal Cell-Free DNA Screening Product Offered
Table 89. Myriad Genetics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Latest Developments
Table 92. GGA Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 93. GGA Prenatal Cell-Free DNA Screening Product Offered
Table 94. GGA Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. GGA Main Business
Table 96. GGA Latest Developments
Table 97. Fulgent Genetics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 98. Fulgent Genetics Prenatal Cell-Free DNA Screening Product Offered
Table 99. Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Fulgent Genetics Main Business
Table 101. Fulgent Genetics Latest Developments
Table 102. BillionToOne Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 103. BillionToOne Prenatal Cell-Free DNA Screening Product Offered
Table 104. BillionToOne Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BillionToOne Main Business
Table 106. BillionToOne Latest Developments
Table 107. BGI Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 108. BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 109. BGI Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Main Business
Table 111. BGI Genomics Latest Developments
Table 112. Berry Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 113. Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 114. Berry Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Main Business
Table 116. Berry Genomics Latest Developments
Table 117. Annaroad Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 118. Annaroad Prenatal Cell-Free DNA Screening Product Offered
Table 119. Annaroad Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Main Business
Table 121. Annaroad Latest Developments
Table 122. Genesky Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 123. Genesky Prenatal Cell-Free DNA Screening Product Offered
Table 124. Genesky Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Genesky Main Business
Table 126. Genesky Latest Developments
Table 127. Weihansi Biomedical Technology Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 128. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product Offered
Table 129. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Weihansi Biomedical Technology Main Business
Table 131. Weihansi Biomedical Technology Latest Developments
Table 132. BGI Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 133. BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 134. BGI Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. BGI Genomics Main Business
Table 136. BGI Genomics Latest Developments
Table 137. Berry Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 138. Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 139. Berry Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Berry Genomics Main Business
Table 141. Berry Genomics Latest Developments
Table 142. Annaroad Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 143. Annaroad Prenatal Cell-Free DNA Screening Product Offered
Table 144. Annaroad Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Annaroad Main Business
Table 146. Annaroad Latest Developments
Table 147. Genesky Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 148. Genesky Prenatal Cell-Free DNA Screening Product Offered
Table 149. Genesky Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Genesky Main Business
Table 151. Genesky Latest Developments
Table 1. Prenatal Cell-Free DNA Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Prenatal Cell-Free DNA Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Condition Screening
Table 4. Major Players of Expanded Condition Screening
Table 5. Prenatal Cell-Free DNA Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Whole Genome Sequencing
Table 9. Major Players of Targeted Sequencing
Table 10. Major Players of Others
Table 11. Prenatal Cell-Free DNA Screening Market Size CAGR by Sequencing Method (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Prenatal Cell-Free DNA Screening Market Size by Sequencing Method (2021-2026) & ($ millions)
Table 13. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method (2021-2026)
Table 14. Major Players of Public Health Program
Table 15. Major Players of Consumer
Table 16. Major Players of Others
Table 17. Prenatal Cell-Free DNA Screening Market Size CAGR by Service Model (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global Prenatal Cell-Free DNA Screening Market Size by Service Model (2021-2026) & ($ millions)
Table 19. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model (2021-2026)
Table 20. Prenatal Cell-Free DNA Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 22. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 23. Global Prenatal Cell-Free DNA Screening Revenue by Player (2021-2026) & ($ millions)
Table 24. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player (2021-2026)
Table 25. Prenatal Cell-Free DNA Screening Key Players Head office and Products Offered
Table 26. Prenatal Cell-Free DNA Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 30. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 31. Global Prenatal Cell-Free DNA Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 35. Americas Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Table 37. Americas Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Table 39. APAC Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Table 41. APAC Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country (2021-2026)
Table 45. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of Prenatal Cell-Free DNA Screening
Table 51. Key Market Challenges & Risks of Prenatal Cell-Free DNA Screening
Table 52. Key Industry Trends of Prenatal Cell-Free DNA Screening
Table 53. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global Prenatal Cell-Free DNA Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Natera Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 58. Natera Prenatal Cell-Free DNA Screening Product Offered
Table 59. Natera Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Natera Main Business
Table 61. Natera Latest Developments
Table 62. Labcorp Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 63. Labcorp Prenatal Cell-Free DNA Screening Product Offered
Table 64. Labcorp Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Labcorp Main Business
Table 66. Labcorp Latest Developments
Table 67. Quest Diagnostics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 68. Quest Diagnostics Prenatal Cell-Free DNA Screening Product Offered
Table 69. Quest Diagnostics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Quest Diagnostics Main Business
Table 71. Quest Diagnostics Latest Developments
Table 72. MedGenome Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 73. MedGenome Prenatal Cell-Free DNA Screening Product Offered
Table 74. MedGenome Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. MedGenome Main Business
Table 76. MedGenome Latest Developments
Table 77. Mayo Clinic Laboratories Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 78. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Product Offered
Table 79. Mayo Clinic Laboratories Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Mayo Clinic Laboratories Main Business
Table 81. Mayo Clinic Laboratories Latest Developments
Table 82. SYNLAB Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 83. SYNLAB Prenatal Cell-Free DNA Screening Product Offered
Table 84. SYNLAB Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. SYNLAB Main Business
Table 86. SYNLAB Latest Developments
Table 87. Myriad Genetics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 88. Myriad Genetics Prenatal Cell-Free DNA Screening Product Offered
Table 89. Myriad Genetics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Latest Developments
Table 92. GGA Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 93. GGA Prenatal Cell-Free DNA Screening Product Offered
Table 94. GGA Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. GGA Main Business
Table 96. GGA Latest Developments
Table 97. Fulgent Genetics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 98. Fulgent Genetics Prenatal Cell-Free DNA Screening Product Offered
Table 99. Fulgent Genetics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Fulgent Genetics Main Business
Table 101. Fulgent Genetics Latest Developments
Table 102. BillionToOne Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 103. BillionToOne Prenatal Cell-Free DNA Screening Product Offered
Table 104. BillionToOne Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BillionToOne Main Business
Table 106. BillionToOne Latest Developments
Table 107. BGI Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 108. BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 109. BGI Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Main Business
Table 111. BGI Genomics Latest Developments
Table 112. Berry Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 113. Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 114. Berry Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Main Business
Table 116. Berry Genomics Latest Developments
Table 117. Annaroad Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 118. Annaroad Prenatal Cell-Free DNA Screening Product Offered
Table 119. Annaroad Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Main Business
Table 121. Annaroad Latest Developments
Table 122. Genesky Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 123. Genesky Prenatal Cell-Free DNA Screening Product Offered
Table 124. Genesky Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 125. Genesky Main Business
Table 126. Genesky Latest Developments
Table 127. Weihansi Biomedical Technology Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 128. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Product Offered
Table 129. Weihansi Biomedical Technology Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 130. Weihansi Biomedical Technology Main Business
Table 131. Weihansi Biomedical Technology Latest Developments
Table 132. BGI Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 133. BGI Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 134. BGI Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 135. BGI Genomics Main Business
Table 136. BGI Genomics Latest Developments
Table 137. Berry Genomics Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 138. Berry Genomics Prenatal Cell-Free DNA Screening Product Offered
Table 139. Berry Genomics Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 140. Berry Genomics Main Business
Table 141. Berry Genomics Latest Developments
Table 142. Annaroad Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 143. Annaroad Prenatal Cell-Free DNA Screening Product Offered
Table 144. Annaroad Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 145. Annaroad Main Business
Table 146. Annaroad Latest Developments
Table 147. Genesky Details, Company Type, Prenatal Cell-Free DNA Screening Area Served and Its Competitors
Table 148. Genesky Prenatal Cell-Free DNA Screening Product Offered
Table 149. Genesky Prenatal Cell-Free DNA Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 150. Genesky Main Business
Table 151. Genesky Latest Developments
LIST OF FIGURES
Figure 1. Prenatal Cell-Free DNA Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Prenatal Cell-Free DNA Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2025)
Figure 8. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 10. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method in 2025
Figure 11. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model in 2025
Figure 12. Prenatal Cell-Free DNA Screening in Public Hospitals
Figure 13. Global Prenatal Cell-Free DNA Screening Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Prenatal Cell-Free DNA Screening in Private Hospitals
Figure 15. Global Prenatal Cell-Free DNA Screening Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 17. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player in 2025
Figure 18. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Prenatal Cell-Free DNA Screening Value Market Share by Country in 2025
Figure 24. United States Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region in 2025
Figure 29. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country in 2025
Figure 38. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 61. China Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 65. India Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 68. France Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 1. Prenatal Cell-Free DNA Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Prenatal Cell-Free DNA Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2025)
Figure 8. Prenatal Cell-Free DNA Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2025
Figure 10. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Sequencing Method in 2025
Figure 11. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Service Model in 2025
Figure 12. Prenatal Cell-Free DNA Screening in Public Hospitals
Figure 13. Global Prenatal Cell-Free DNA Screening Market: Public Hospitals (2021-2026) & ($ millions)
Figure 14. Prenatal Cell-Free DNA Screening in Private Hospitals
Figure 15. Global Prenatal Cell-Free DNA Screening Market: Private Hospitals (2021-2026) & ($ millions)
Figure 16. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2025
Figure 17. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Player in 2025
Figure 18. Global Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Prenatal Cell-Free DNA Screening Value Market Share by Country in 2025
Figure 24. United States Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Region in 2025
Figure 29. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Country in 2025
Figure 38. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Prenatal Cell-Free DNA Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 61. China Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 65. India Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 68. France Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Prenatal Cell-Free DNA Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Prenatal Cell-Free DNA Screening Market Size 2027-2032 ($ millions)
